Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.5.3 was added to the record history. The previous revision v3.5.2 was removed from the list.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page updates its displayed software revision from v3.5.0 to v3.5.2. No trial-specific content changes are shown.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a new version entry: Revision: v3.5.0, and removed the entry: Revision: v3.4.3, in the study record history.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1); this is metadata about page revisions and does not alter study information or display.SummaryDifference0.1%

- Check83 days agoChange DetectedThe History page now shows Revision: v3.4.1 added and Revision: v3.4.0 removed, a minor update to the version history display (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.1%

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.